Also categorized in Health Technology:
For CRISPR, Tweaking DNA Fragments Before Inserting Yields Highest Efficiency Rates Yet
x hide permanently

Novel Radiotracer Is an Effective Option for Staging of Prostate Cancer

Medical News

The novel radiopharmaceutical 18F-PSMA-1007 is both effective and readily available for detecting malignant prostate cancer lesions, according to research published in the April issue of The Journal of Nuclear Medicine. With this new option and 68Ga-PSMA-11, which is already widely used, nuclear medicine departments will have two effective options for staging of prostate cancer, potentially increasing availability for patients worldwide.

68Ga-PSMA is the most commonly used PSMA-labeled tracer in clinical practice for evaluating extent of disease in prostate cancer patients. However, it is produced by a specific generator and has a short half-life of 68 minutes.

The prospective ...